These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 15113998

  • 1. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.
    Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP.
    Rheumatology (Oxford); 2004 Jun; 43(6):790-4. PubMed ID: 15113998
    [Abstract] [Full Text] [Related]

  • 2. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.
    Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A.
    J Rheumatol; 2007 Jan; 34(1):123-9. PubMed ID: 17216680
    [Abstract] [Full Text] [Related]

  • 3. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study.
    McHugh NJ, Balachrishnan C, Jones SM.
    Rheumatology (Oxford); 2003 Jun; 42(6):778-83. PubMed ID: 12730539
    [Abstract] [Full Text] [Related]

  • 4. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
    Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen CF, Salvarani C, Thaci D, Toloza SM, Wong MY, Zhou QM, Gladman DD.
    Arthritis Rheum; 2009 Sep 15; 61(9):1235-42. PubMed ID: 19714610
    [Abstract] [Full Text] [Related]

  • 5. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices.
    Gottlieb AB, Mease PJ, Mark Jackson J, Eisen D, Amy Xia H, Asare C, Stevens SR.
    J Dermatolog Treat; 2006 Sep 15; 17(5):279-87. PubMed ID: 17092858
    [Abstract] [Full Text] [Related]

  • 6. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.
    Arthritis Rheum; 2005 Apr 15; 52(4):1227-36. PubMed ID: 15818699
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study.
    Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, McGonagle D.
    Rheumatology (Oxford); 2007 Feb 15; 46(2):253-6. PubMed ID: 16837473
    [Abstract] [Full Text] [Related]

  • 9. Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study.
    Love TJ, Gudjonsson JE, Valdimarsson H, Gudbjornsson B.
    Scand J Rheumatol; 2010 Aug 15; 39(4):299-302. PubMed ID: 20476857
    [Abstract] [Full Text] [Related]

  • 10. Nail and distal interphalangeal joint in psoriatic arthritis.
    Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A, Spanò A, Sirignano C, Oriente A, Di Minno MN, Iervolino S, Salvatore M.
    J Rheumatol; 2006 Jul 15; 33(7):1315-9. PubMed ID: 16758507
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D, Gregoriou S, Stratigos A, Larios G, Korfitis C, Papaioannou D, Antoniou C, Ioannides D.
    Br J Dermatol; 2008 Aug 15; 159(2):453-6. PubMed ID: 18565184
    [Abstract] [Full Text] [Related]

  • 12. Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms.
    Taylor SL, Petrie M, O'Rourke KS, Feldman SR.
    J Dermatolog Treat; 2009 Aug 15; 20(6):350-3. PubMed ID: 19878036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F.
    Br J Dermatol; 2008 Aug 15; 159(2):322-30. PubMed ID: 18503600
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
    Luger TA, Barker J, Lambert J, Yang S, Robertson D, Foehl J, Molta CT, Boggs R.
    J Eur Acad Dermatol Venereol; 2009 Aug 15; 23(8):896-904. PubMed ID: 19453794
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Psoriatic nail involvement and its relationship with distal interphalangeal joint disease.
    Lai TL, Pang HT, Cheuk YY, Yip ML.
    Clin Rheumatol; 2016 Aug 15; 35(8):2031-2037. PubMed ID: 27251673
    [Abstract] [Full Text] [Related]

  • 20. Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology.
    Gladman DD, Chandran V, Thavaneswaran A, Zummer M.
    J Rheumatol; 2012 Sep 15; 39(9):1850-3. PubMed ID: 22859361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.